Akèy › Kansè Poumon ki pa ti selil › Illinois › Aurora
Etid klinik pou Kansè Poumon ki pa ti selil nan Aurora, IL
11 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Aurora (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Rush-Copley Medical Center, Aurora
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Rush-Copley Medical Center, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi lwen
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Ap rekriteFaz 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Advocate Outpatient Center - Aurora, Aurora
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Advocate Outpatient Center - Aurora, Aurora
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi lwen
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Aurora
- Kansè poumon11 etid
- Kansè pwostat9 etid
- Melanom7 etid
- Kansè nan tete7 etid
- Karsinòm selil skuamèz tèt ak kou5 etid
- Kansè ovè5 etid
- Kansè (tout kalite)4 etid
- Kansè renn (Kasinom selil renn)4 etid
- Kansè Ipofaringe4 etid
- Kansè larinks4 etid
- Kansè bouch4 etid
- Leksemi mieloïd egi4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.